ArticleOncogene2021

MITF is a driver oncogene and potential therapeutic target in kidney angiomyolipoma tumors through transcriptional regulation of CYR61.

Mahsa Zarei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.